ArticleProceedings of the National Academy of Sciences of the United States of America2025

eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer.

Jacob A Boyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.